Effect of Acute, Subacute, and Repeated Exposure to High Altitude (5050 m) on Psychomotor Vigilance by Pun, Matiram et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2018
Effect of Acute, Subacute, and Repeated Exposure to High Altitude (5050
m) on Psychomotor Vigilance
Pun, Matiram; Hartmann, Sara E; Furian, Michael; Dyck, Adrienna M; Muralt, Lara; Lichtblau, Mona;
Bader, Patrick R; Rawling, Jean M; Ulrich, Silvia; Bloch, Konrad E; Poulin, Marc J
Abstract: High altitude (HA) hypoxia may affect cognitive performance and sleep quality. Further,
vigilance is reduced following sleep deprivation. We investigated the effect on vigilance, actigraphic
sleep indices, and their relationships with acute mountain sickness (AMS) during very HA exposure,
acclimatization, and re-exposure. A total of 21 healthy altitude-naive individuals (25 ± 4 years; 13
females) completed 2 cycles of altitude exposure separated by 7 days at low altitude (LA, 520 m).
Participants slept at 2900 m and spent the day at HA, (5050 m). We report acute altitude exposure on Day
1 (LA vs. HA1) and after 6 days of acclimatization (HA1 vs. HA6). Vigilance was quantified by reaction
speed in the 10-min psychomotor vigilance test reaction speed (PVT-RS). AMS was evaluated using
the Environmental Symptoms Questionnaire Cerebral Score (AMS-C score). Nocturnal rest/activity was
recorded to estimate sleep duration using actigraphy. In , PVT-RS was slower at HA1 compared to LA
(4.1 ± 0.8 vs. 4.5 ± 0.6 s, respectively, = 0.029), but not at HA6 (4.6 ± 0.7; > 0.05). In , PVT-RS at HA1
(4.6 ± 0.7) and HA6 (4.8 ± 0.6) were not different from LA (4.8 ± 0.6, > 0.05) and significantly greater
than corresponding values in . In both cycles, AMS scores were higher at HA1 than at LA and HA6 ( <
0.05). Estimated sleep durations (TST) at LA, 1st and 5th nights were 431.3 ± 28.7, 418.1 ± 48.6, and
379.7 ± 51.4 min, respectively, in and they were significantly reduced during acclimatization exposures
(LA vs. 1st night, > 0.05; LA vs. 5th night, = 0.012; and 1st vs. 5th night, = 0.054). LA, 1st and 5th
nights TST in were 477.5 ± 96.9, 430.9 ± 34, and 341.4 ± 32.2, respectively, and we observed similar
deteriorations in TST as in (LA vs. 1st night, > 0.05; LA vs. 5th night, = 0.001; and 1st vs. 5th night,
< 0.0001). At HA1, subjects who reported higher AMS-C scores exhibited slower PVT-RS ( = -0.56; <
0.01). Subjects with higher AMS-C scores took longer time to react to the stimuli during acute exposure
( = 0.62, < 0.01) during HA1 of . Acute exposure to HA reduces the PVT-RS. Altitude acclimatization
over 6 days recovers the reaction speed and prevents impairments during subsequent altitude re-exposure
after 1 week spent near sea level. However, acclimatization does not lead to improvement in total sleep
time during acute and subacute exposures.
DOI: https://doi.org/10.3389/fphys.2018.00677
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-160565
Journal Article
Published Version
 
 
The following work is licensed under a Creative Commons: Attribution 4.0 International (CC BY 4.0)
License.
Originally published at:
Pun, Matiram; Hartmann, Sara E; Furian, Michael; Dyck, Adrienna M; Muralt, Lara; Lichtblau, Mona;
Bader, Patrick R; Rawling, Jean M; Ulrich, Silvia; Bloch, Konrad E; Poulin, Marc J (2018). Effect of
Acute, Subacute, and Repeated Exposure to High Altitude (5050 m) on Psychomotor Vigilance. Frontiers
in Physiology, 9:677.
DOI: https://doi.org/10.3389/fphys.2018.00677
2
fphys-09-00677 May 31, 2018 Time: 17:23 # 1
CLINICAL TRIAL
published: 04 June 2018
doi: 10.3389/fphys.2018.00677
Edited by:
Jean-Paul Richalet,
Université Paris 13, France
Reviewed by:
Simona Mrakic-Sposta,
Istituto di Bioimmagini e Fisiologia
Molecolare (IBFM), Italy
Alessandro Tonacci,
Istituto di Fisiologia Clinica (IFC), Italy
*Correspondence:
Marc J. Poulin
poulin@ucalgary.ca
Specialty section:
This article was submitted to
Integrative Physiology,
a section of the journal
Frontiers in Physiology
Received: 05 February 2018
Accepted: 15 May 2018
Published: 04 June 2018
Citation:
Pun M, Hartmann SE, Furian M,
Dyck AM, Muralt L, Lichtblau M,
Bader PR, Rawling JM, Ulrich S,
Bloch KE and Poulin MJ (2018)
Effect of Acute, Subacute,
and Repeated Exposure to High
Altitude (5050 m) on Psychomotor
Vigilance. Front. Physiol. 9:677.
doi: 10.3389/fphys.2018.00677
Effect of Acute, Subacute, and
Repeated Exposure to High Altitude
(5050 m) on Psychomotor Vigilance
Matiram Pun1,2, Sara E. Hartmann1,2, Michael Furian3, Adrienna M. Dyck1,2,4,
Lara Muralt3, Mona Lichtblau3, Patrick R. Bader3, Jean M. Rawling5, Silvia Ulrich3,
Konrad E. Bloch3 and Marc J. Poulin1,2,4,6,7,8*
1 Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada,
2 Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 3 Pulmonary Division,
Sleep Disorders Centre and Pulmonary Hypertension Clinic, University Hospital Zurich, Zurich, Switzerland, 4 Faculty of
Kinesiology, University of Calgary, Calgary, AB, Canada, 5 Department of Family Medicine, Cumming School of Medicine,
University of Calgary, Calgary, AB, Canada, 6 Libin Cardiovascular Institute of Alberta, Cumming School of Medicine,
University of Calgary, Calgary, AB, Canada, 7 O’Brien Institute for Public Health, Cumming School of Medicine, University of
Calgary, Calgary, AB, Canada, 8 Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary,
Calgary, AB, Canada
Aim: High altitude (HA) hypoxia may affect cognitive performance and sleep quality.
Further, vigilance is reduced following sleep deprivation. We investigated the effect on
vigilance, actigraphic sleep indices, and their relationships with acute mountain sickness
(AMS) during very HA exposure, acclimatization, and re-exposure.
Methods: A total of 21 healthy altitude-naive individuals (25 ± 4 years; 13 females)
completed 2 cycles of altitude exposure separated by 7 days at low altitude (LA, 520 m).
Participants slept at 2900 m and spent the day at HA, (5050 m). We report acute
altitude exposure on Day 1 (LA vs. HA1) and after 6 days of acclimatization (HA1 vs.
HA6). Vigilance was quantified by reaction speed in the 10-min psychomotor vigilance
test reaction speed (PVT-RS). AMS was evaluated using the Environmental Symptoms
Questionnaire Cerebral Score (AMS-C score). Nocturnal rest/activity was recorded to
estimate sleep duration using actigraphy.
Results: In Cycle 1, PVT-RS was slower at HA1 compared to LA (4.1 ± 0.8 vs.
4.5 ± 0.6 s−1, respectively, p = 0.029), but not at HA6 (4.6 ± 0.7; p > 0.05). In
Cycle 2, PVT-RS at HA1 (4.6 ± 0.7) and HA6 (4.8 ± 0.6) were not different from LA
(4.8 ± 0.6, p > 0.05) and significantly greater than corresponding values in Cycle 1. In
both cycles, AMS scores were higher at HA1 than at LA and HA6 (p < 0.05). Estimated
sleep durations (TST) at LA, 1st and 5th nights were 431.3 ± 28.7, 418.1 ± 48.6, and
379.7 ± 51.4 min, respectively, in Cycle 1 and they were significantly reduced during
acclimatization exposures (LA vs. 1st night, p > 0.05; LA vs. 5th night, p = 0.012; and
1st vs. 5th night, p = 0.054). LA, 1st and 5th nights TST in Cycle 2 were 477.5 ± 96.9,
430.9 ± 34, and 341.4 ± 32.2, respectively, and we observed similar deteriorations in
TST as in Cycle 1 (LA vs. 1st night, p > 0.05; LA vs. 5th night, p = 0.001; and 1st vs.
5th night, p < 0.0001). At HA1, subjects who reported higher AMS-C scores exhibited
slower PVT-RS (r = −0.56; p < 0.01). Subjects with higher AMS-C scores took longer
time to react to the stimuli during acute exposure (r = 0.62, p < 0.01) during HA1 of
Cycle 1.
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Conclusion: Acute exposure to HA reduces the PVT-RS. Altitude acclimatization over
6 days recovers the reaction speed and prevents impairments during subsequent
altitude re-exposure after 1 week spent near sea level. However, acclimatization does
not lead to improvement in total sleep time during acute and subacute exposures.
Keywords: altitude, psychomotor vigilance task, actigraphy, sleep, hypoxia, brain
INTRODUCTION
High altitude (HA) exposure is associated with low blood oxygen
saturation due to the decreased partial pressure of oxygen as a
result of reduced barometric pressure (West, 1996). Compared
to slow acclimatizing trekking, rapid ascent to HA (via motor
vehicle or air travel, for example) leads to profound hypoxemia
and related pathophysiological consequences (Murdoch, 1995;
West, 2008; Bloch et al., 2009; Strapazzon et al., 2015). The
physiological responses to HA exposure include heart rate
elevation, increased ventilation, and diuresis and fatigue on
exertion (Nussbaumer-Ochsner and Bloch, 2007; Richalet et al.,
2012; Luks, 2015). Failure to acclimatize due to rapid ascent
leads to acute altitude illness such as acute mountain sickness
(AMS) (Hackett and Roach, 2001; Bartsch and Swenson, 2013;
Luks et al., 2017). The continuous gain in elevation and
prolonged exposure to altitude can lead to adverse neurological
consequences (Basnyat et al., 2004; Wilson et al., 2009; Strapazzon
et al., 2014; Phillips et al., 2017) and possibly impaired
cognitive function although this has not been consistently
demonstrated (Latshang et al., 2013; Roach et al., 2014; Beer et al.,
2017).
Sleep disturbance is reported commonly during altitude
exposure (Johnson et al., 2010; Latshang et al., 2013; Bloch
et al., 2015) due to hypoxia and new environmental conditions
such as cold, uncomfortable sleeping quarters, and disturbed
sleep due to increased frequency of urination (Windsor and
Rodway, 2012). Further, exposure to HA is associated with a
higher incidence of periodic breathing (Bloch et al., 2010; Ainslie
et al., 2013), a disturbance of ventilatory control commonly
observed in HA sojourners. Periodic breathing is characterized
by waxing and waning ventilation, punctuated with periods of
hyperventilation and then central apneas or hypopneas. Affected
individuals often suffer from frequent arousals and poor sleep
(Nussbaumer-Ochsner et al., 2012).
Poor sleep at altitude may affect daytime performance,
especially of those tasks that require sustained attention and
delicate fine-motor dexterity. The speed of response to light
stimuli in the psychomotor vigilance test (PVT), a validated
indicator of alertness, is slower following sleep deprivation (Van
Dongen and Dinges, 2005; Lim and Dinges, 2008). Several studies
have reported negative effects of sleep-disordered breathing (Kim
et al., 2007; Lee et al., 2011; Kitamura et al., 2017), sleep
deprivation (Van Dongen and Dinges, 2005; Lim and Dinges,
2008), and HA exposure (Latshang et al., 2013; Roach et al.,
2014) on psychomotor vigilance tasks. Hence, these conditions
could have deleterious consequences for individuals at HA
performing work that demands continuous attention, decision-
making, delicate handling of tools, and heavy-duty machinery
work.
The Atacama Large Millimeter/submillimeter Array (ALMA)
Observatory at 5050 m above sea level (asl) in Chile provides
a unique pattern of repeated high-altitude exposure. Scientists
from all over the world visit the site periodically to conduct
scientific observations, experiments, and data collection. Further,
lowland-native Chileans work there in various capacities,
including equipment maintenance, security operations, scientific
data collection, and reporting. A normal commute schedule
includes typically, flight to Calama (2900 m asl) from Santiago
(520 m asl) and travel about 2 h by bus to the ALMA basecamp
(2900 m asl). From there, for a week at a time they ascend to the
ALMA Observatory. Workers then spend the day working at HA
and return to basecamp by motor vehicle in the evening. These
workers suffer from periodic hypoxia (∼6–8 h/day) at very HA,
and then sleep in a hypoxic environment at HA. After a week
of HA work, the workers descend to their altitude of residence
near sea level to rest, before returning to work at HA for another
cycle. This pattern repeats itself continuously. How this type
of HA exposure affects immediate and long-term health, and
consequently work performance, is unknown. Both poor sleep
and hypobaric hypoxia at altitude may be related to impaired
vigilant attention, thereby affecting daytime task performance.
To investigate the impact of very HA exposure on vigilant
attention, we brought a group of young, healthy, altitude-naive
individuals to the ALMA Observatory, Chile. We mimicked the
pattern of hypoxia exposure that is experienced by workers, in
order to study the acute and subacute effects of repeated very HA
exposure over two work-shift cycles (i.e., approximately 4 weeks).
We had three specific goals in this high-altitude research
expedition. First, we wanted to study the effect of acute, subacute,
and re-exposure to very HA on PVT reaction speed (PVT-
RS) in healthy, young, altitude-naive individuals. Second, we
wanted to assess relationships between PVT-RS, AMS-Cerebral
(AMS-C) score, blood oxygen saturation and sleep indices as
measured by actigraphy. Third, we wanted to explore whether
acclimatization obtained in previous exposure is retained during
subsequent exposures after 1 week of rest at low altitude (LA).
We hypothesized that immediate exposure to very HA would
be associated with a slower PVT-RS, worsened sleep indices and
increased prevalence of AMS. We further hypothesized that these
parameters would improve upon acclimatization, and would be
less affected with repeated exposure to altitude.
MATERIALS AND METHODS
Study Design and Setting
The study was carried out in Atacama Desert of northern Chile.
Baseline measurements were taken in Santiago (520 m asl).
After baseline measurements, the study participants traveled
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approximately 2 h by air followed by a 2-h bus to the
ALMA Operation Support Facility (ASF; 2900 m asl), which
serves as ALMA’s basecamp. Participants slept at the ASF for
7 nights and ascended by motor vehicle (∼45 min) to the
AOS/ALMA to spend ∼7 h (range 4–8 h) per day at very HA.
The ascent profile over 3 weeks from Santiago to the AOS
has been illustrated in Figure 1. Altitude PVT measurements
were taken at the ALMA Operation Site (AOS; 5050 m asl)
located on the Chajnantor Plateau of the Atacama Desert.
Actigraphy was performed over the span of a week cycle
at 5050 and 2900 m sleep altitude, respectively. There were
two 7-day cycles of HA exposure, separated by a break of
7 days at LA (Santiago, 520 m asl) (see schedule illustrated
in Figure 1). The study participants’ high-altitude exposure
schedule was designed to emulate that of workers at the ALMA
Observatory.
Participants
A total of 21 healthy altitude-naive individuals were recruited
for the expedition. A total of 18 subjects were residents
of Calgary and surrounding area (altitude 1100 m asl) in
Canada and were screened for inclusion in the study at the
Foothills Medical Center, Cumming School of Medicine,
University of Calgary, Calgary, AB, Canada. Three subjects
were from Zurich and surrounding area (altitude 490 m asl)
in Switzerland and were screened at University Hospital
of Zurich. Exclusion criteria included previous altitude
intolerance < 3000 m, pregnancy and health impairment,
which requires regular treatment. The screening criteria
adhered to the ALMA HA Medical Examination guidelines.
All participants provided written informed consent. The
study was approved by the Conjoint Health Research
Ethics Board of The University of Calgary (Ethics ID: REB
15-2709) and the Cantonal Ethics Committee of Zurich
(2016-00048) and was registered at ClinicalTrials.gov
(NCT02731456).
Data Collection
The data collection was conducted over nine separate testing
sessions before, during, and after two 7-day cycles at HA.
The baseline and recovery measurements were taken at
Santiago, Chile (520 m asl) while altitude data were collected
at ALMA Observatory site (5050 m asl). Participants were
familiarized with the measurements upon arrival in Santiago,
whereas baseline measurements were performed on the
day after. The objective of familiarization session was to
make study participants familiar with experimental sessions,
scoring sheets, instrumentation, and nature of invasiveness.
The sleep data, acquired using actigraphy, were collected at
the sleep altitudes (Santiago and the ASF) throughout the
cycle, i.e., every night. The participants wore Actiwatches
continuously throughout the expedition cycles unless otherwise
due to technical and logistical reasons. The experimental
sessions or specific data collection time points during
HA exposure on the specific days have been illustrated in
Figure 1.
Psychomotor Vigilance Test and Trail
Making Test
Since speed of psychomotor response to light stimuli is adversely
affected following sleep deprivation (Sforza et al., 2004; Dorian
et al., 2005; Basner and Dinges, 2011; Basner et al., 2011;
Batool-Anwar et al., 2014), we utilized PVT-RS as a tool in
assessing daytime function at altitude. Psychomotor vigilance was
determined using a standard 10-min duration PVT assessment,
previously described (Dorian et al., 2005; Drummond et al.,
2005; Basner and Dinges, 2011). Time to react to randomly
generated light stimuli was measured using a handheld Multiple
Unprepared Reaction Time Test (MURT) device (Latshang et al.,
2013). Several responses were obtained within a 10-min period,
and the outcome was the mean reciprocal value of the RT (i.e.,
1/RT). The PVT is a well-validated tool for vigilant attention
deficits as a measure of neurobehavioral reaction speed due
to sleep loss or deprivation (Basner and Dinges, 2011). The
trail making tests (TMT) were administered in pen and paper
version which contained circles containing numbers (Allen and
Haderlie, 2010). The participants were instructed to connect
circled numbers in sequence as quickly as possible without
making an error. Whenever an error was made, the participants
were asked to start again from the point where they made
the error and continue. The times to complete the TMT were
recorded in seconds.
Sleep Monitoring: Actigraphy
Wrist actigraphy was recorded to estimate nocturnal rest as
a surrogate of sleep (Latshang et al., 2016) (Actigraph 2.0,
Minimitter; Philips Respironics, Murrysville, PA, United States).
All participants wore an actimeter for a total of 9 days,
including the baseline and recovery period at LA (520 m asl,
Santiago) and 7 days at HA (2900 m asl, ALMA Operation
Support Facility). The actigraphic data collected from the field
were analyzed by the manufacturer’s guidelines and dedicated
software (Respironics Actiware, Version 6.0.4). The data were
exported and assessed by research team members experienced
with Actigraphy. The variables analyzed from the actigraphy
included total time in bed (i.e., time from lights-off to lights-on
which each participant pressed marker switch in the Actiwatch
and also recorded in the sleep diary), total estimated sleep time
(TST; i.e., the sum of all epochs with activity below threshold),
sleep efficiency (i.e., TST in percentage of time in bed), and
sleep latency (i.e., time from lights-off to the beginning of the
first three consecutive epochs with activity below the threshold)
as described in the previous literature (Latshang et al., 2016).
The definitions of sleep parameters such as awakenings and data
analysis was carried out using the Actiware scoring algorithm as
described previously (Drogos et al., 2016). The participants wore
Actiwatches throughout the expedition.
Acute Mountain Sickness Assessment
and Vital Signs
Acute mountain sickness (AMS) was assessed using the Lake
Louise Score (LLS) (Roach et al., 1993) and Environmental
Symptom Questionnaire (ESQ) – Cerebral (AMS-C subscore)
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FIGURE 1 | Expedition schedule and data collection time points. The Y-axis depicts altitude (meters), and the X-axis depicts the days of the entire expedition with
two cycles at high altitude interspersed with 1 week at LA. The numbers within the large black circles depict time points of data collection. The small black circles
with checkmark indicate the sleep nights with actigraphy, i.e., actigraphic data collection time points. The gray shaded horizontal part at the base of each cycle
indicates Cycle 1 and Cycle 2. “1-Week” with a dashed line connecting two cycles indicates time spent at LA. HA1, high altitude exposure at 5050 m asl on Day 1;
HA6, high altitude exposure at 5050 m asl on Day 6 on the respective cycles of expedition; FL, familiarization; BL, baseline; REC, recovery; m, meters; n, numbers.
(Sampson et al., 1983). AMS diagnosis was made based on the
LLS score of ≥ 5, and ESQ AMS-C weighted average score ≥ 0.7
(Maggiorini et al., 1998; Dellasanta et al., 2007; Nussbaumer-
Ochsner et al., 2011). We have used AMS-C score for the analysis
and interpretation. Handgrip (HG) strength was measured in
the dominant hand using a strain-gauge dynamometer following
manufacturer’s guideline (Lafayette, IN, United States). The
HG peak strength has been reported in kilograms (kg). The
resting arm blood pressure was recorded with automatic blood
pressure monitor (Omron Healthcare, Inc., United States) in a
comfortable sitting position. Blood oxygen saturation and heart
rate were measured with a pulse oximetry.
Data Analyses and Statistics
The data collected at different time points during the HA
expedition have been expressed as the mean± standard deviation
(mean ± SD). The effects of altitude [baseline at sea level vs. HA
exposure at Day 1 (i.e., acute exposure; HA1) and HA exposure
at Day 6 (i.e., acclimatization; HA6)] were assessed with one-
way repeated measures of analysis of variance (ANOVA) for each
cycle independently. The sleep parameters were analyzed over
different time points of sleep at HA (i.e., number of nights).
In the second step of the analysis, three time-points (baseline,
acute exposure, and acclimatization effects) were compared with
repeated measures ANOVA to tease out acute (1st night sleep
at HA) and acclimatization effects (fifth-night sleep) of altitude
exposure in each cycle separately. Bivariate correlations were
tested between variables of interest (reaction speed or changes in
the reaction time with AMS score) using Pearson’s correlation
coefficient. Multivariate regression analysis was performed to
identify independent variables (SpO2, AMS-C score, and TST)
associated with PVT-RS at HA1 and HA6 of both cycles to explore
independent as well as interaction effects. The results were
considered significant when the value of alpha was less than 0.05
(p < 0.05) after Bonferroni’s post hoc corrections, as appropriate.
The recovery values were compared with baseline and HA values
with two-tailed paired t-tests wherever necessary to explore the
recovery status of the individuals. All the data analyses were
carried out using the Statistical Package for the Social Sciences
(SPSS), Version 24, IBM Corporation, United States.
RESULTS
A total of 21 healthy altitude-naive individuals aged, mean± SD,
25.3 ± 3.8 years (8 males, 13 females) with body mass
index of 22.8 ± 3.0 kg/m2 were recruited. The baseline
characteristics such as weight (65.4 ± 9.3 kg), body mass
index (22.7 ± 3.1 kg/m2), heart rate (65.5 ± 9.2 bpm), blood
pressure (SBP = 114.2 ± 8.1 mmHg, DBP = 69.9 ± 6.2 mmHg,
MAP = 84.7 ± 5.8 mmHg), peak HG strength (39.4 ± 13.1 kg)
were taken at Santiago, Chile (520 m asl). The absoulte values
from acute (HA1), acclimatization (HA6), and recovery (REC)
sessions have been summarized in Table 1.
The sustained attention test (i.e., PVT) assessed by the
MURT test device has been illustrated in Figure 2. The number
of mistakes/lapses was not statistically significant during HA
exposure although there was a trend to increase with acute
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exposure in both cycles. The individuals took a longer time
to react (increase in mean and median reaction times) at
HA during acute exposure (HA1), and they improved during
acclimatization visit (HA6) in Cycle 1, but they were not
significantly prolonged in Cycle 2 compared to their respective
baselines. The PVT-RS was impaired during acute exposure but
improved in subsequent exposure. The PVT-RS was unaffected
during Cycle 2 (i.e., individuals were acclimatized in Cycle 1, as
shown with values at HA6 and retained it during Cycle 2). The
fastest 10% reaction times (i.e., optimum response times) did
not significantly change at HA in both cycles but the slowest
10% reaction times (i.e., response times in the lapse domain)
increased during acute exposure (HA1) and improved during
acclimatization visits (HA6) in both cycles. The PVT parameters
from baseline, acute exposure (HA1), acclimatization (HA6),
and recovery (REC) have been illustrated in Figure 2. We also
incorporated the trail-making test (TMT) which did not get
worse during acute exposures (HA1) but improved during the
acclimatization exposures (HA6) compared to baseline in both
Cycles. There was a significantly higher incidence of AMS during
the first exposure but not during the acclimatization exposure
with both scoring criteria of AMS [i.e., LLS and ESQ (AMS-C)]
as shown in Table 2.
Actigraphy results are summarized in Table 3. Due to
technical difficulties, data are given only up to the 5th night for 18
individuals in Cycle 1 and 14 individuals in Cycle 2 for the entire
expedition (i.e., 9 nights including baseline, 7 nights at altitude
and recovery) (Table 3). To explore the acute and acclimatization
effects of altitude upon sleep indices, the baseline was compared
with acute exposure (HA1) sleep and after acclimatization (HA6)
sleep in each cycle as illustrated in Figure 3. In Cycle 1, the
altitude had an adverse effect on total sleep time at the 5th
night (i.e., after the acclimatization days). The individuals tended
to spend less time in bed (p = 0.078, 1st vs. 5th nights) while
wakefulness after sleep-onset time tended to increase (p = 0.057,
baseline vs. 5th night) during the acclimatization night although
they were not statistically significant (Figures 3A and B, Cycle 1).
Interestingly, during Cycle 2, participants spent less time in bed
(p = 0.001, baseline vs. 5th night; p < 0.001, 1st vs. 5th nights)
and had decreased total sleep time (p = 0.001, 1st vs. 5th nights;
p < 0.001, 1st vs. 5th nights) during prolonged exposure (5th
night) compared to baseline and 1st night at altitude (Figure 3C).
To find out the break point for the sleep disturbances observed
during acclimatization exposure (5th night), we analyzed sleep
indices of all the nights (N1, N2, N3, N4, and N5) with baseline
(BL) using one-way repeated measures ANOVA (time∗6). The
changes in total sleep time (TST) started on the 3rd night at
altitude in both cycles – Cycle 1 (BL: 431.3 ± 28.7 vs. N3:
369.7± 54.3, p = 0.008 and N1: 418.1± 48.6 vs. N3: 369.7± 54.3,
p = 0.062) and Cycle 2 (BL: 477.5 ± 96.9 vs. N3: 368.9 ± 61.5,
p = 0.097 and N1: 430.9 ± 34 vs. N3: 368.9 ± 61.5, p = 0.021).
The findings were further supported with a series of repeated
measures ANOVA analyses (time∗3) as baseline (BL), acute
exposure (N1, 1st night at altitude), and respective nights (N2,
N3, N4, and N5). We observed significant changes in TST from
3rd night at altitude onward in both cycles – Cycle 1 (BL:
431.3± 28.7 vs. N3: 369.7 ± 54.3, p = 0.002 and N1:418.1± 48.6
vs. N3: 369.7 ± 54.3, p = 0.0125) and Cycle 2 (BL: 477.5 ± 96.9
vs. N3: 368.9 ± 61.5, p = 0.004 and N1:430.9 ± 34 vs. N3:
368.9± 61.5, p = 0.004).
Finally, the acute exposure to HA is associated with increased
incidence of AMS which wears off with acclimatization (Table 2).
The incidence of AMS decreased by > 50% during Cycle 2
(HA1) exposure compared to Cycle 1 (HA1). Next, the AMS-C
score was negatively correlated (r = −0.56, p < 0.01) with PVT-
RS. Altitude adversely affected PVT-RS during acute exposure
and was associated with increased AMS-C scores as illustrated
in Figure 4A. The mean reaction time changes (mean reaction
at altitude – mean reaction time at baseline) were positively
correlated (r = 0.62, p < 0.01) with AMS-C scores i.e., higher
AMS-C scoring individuals took a longer time to react at HA
during acute exposure as shown in Figure 4B. The individuals
recovered during the acclimatization phase (i.e., there was no
such correlation among these parameters); this recovery was
sustained during Cycle 2 even after 1 week of rest at LA.
Multiple regression analyses revealed that AMS-C score (p = 0.01)
but not the total sleep time and blood oxygen saturation
was the independent predictor of PVT-RS during acute HA
exposure (HA1) of Cycle 1 (Table 4). However, the association
was abolished during acclimatization (HA6) and re-exposures
TABLE 1 | Descriptive characteristics of the study participants.
Variables Cycle 1 Cycle 2
Baseline SL HA1 HA6 Recovery SL Baseline SL HA1 HA6 Recovery SL
Weight (kg) 65.4 ± 9.3 65.4 ± 9.1 64.6 ± 9.0 64.7 ± 9.3 64.9 ± 9.0 65.1 ± 9.0 64.3 ± 9.2 64.6 ± 9.1
Body mass index (kg/m2) 22.7 ± 3.1 22.7 ± 3.1 22.5 ± 2.9 22.5 ± 3.0 22.6 ± 3.0 22.6 ± 2.9 22.4 ± 3.0 22.4 ± 2.9
HR (bpm) 65.5 ± 9.2 87.5 ± 14.2 75.9 ± 12.4 61.8 ± 11.5 57.5 ± 10.6 79.8 ± 11.3 74.5 ± 9.3 62.9 ± 9.1
SBP (mmHg) 114.2 ± 8.1 114.7 ± 12.4 117.1 ± 8.2 107.0 ± 9.0 106.7 ± 9.4 111.3 ± 8.7 114.3 ± 10.0 103.6 ± 7.1
DBP (mmHg) 69.9 ± 6.2 72.2 ± 8.9 77.0 ± 8.9 65.7 ± 6.5 65.9 ± 7.3 73.7 ± 7.2 76.2 ± 6.4 62.5 ± 7.4
MAP (mmHg) 84.7 ± 5.8 86.3 ± 9.4 90.3 ± 7.5 79.4 ± 6.9 79.5 ± 7.5 86.2 ± 7.1 88.9 ± 6.6 76.2 ± 6.7
HG peak strength (kg) 39.4 ± 13.1 36.7 ± 10.4a 38.8 ± 12.7 39.9 ± 12.2a 38.0 ± 12.2 36.5 ± 13.9 39.2 ± 12.2 39.9 ± 13.0
The descriptive characteristics of the 21 altitude-naive healthy individuals, who joined the high altitude expedition, born and raised at an altitude of ≤ 1100 m asl. Values
are means ± SD. SL, sea level; HA1, high altitude at day 1; HA6, high altitude day 6; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial
blood pressure; HR, heart rate; mmHg, millimeter of mercury; bpm, beats per minute; HG, handgrip; kg, kilogram; SD, standard deviation; kg, kilogram; m, meter. an = 20,
Sex: Males (8) and Females (13) and average age: 25.3 ± 3.8 years.
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FIGURE 2 | Effect of altitude exposure on PVT parameters during acute and acclimatization exposures. It illustrates changes in different PVT parameters during high
altitude exposure. Four important time points of the expedition are illustrated (BL, baseline at LA; HA1, acute high altitude exposure; HA6, acclimatization exposure
of both cycles; REC, recovery). The Y-axis depicts sleep parameters with the mean and standard deviation (Mean ± SD) of the PVT parameters. The X-axis depicts
different expedition time points (BL1, HA1, HA6, and REC of Cycle 1 and Cycle 2). Solid bars represent Cycle 1 exposure while empty bars represent Cycle 2
exposure. Here, panel A illustrates number of errors/lapses while panel E represents PVT reaction speed. Panels B and F represent mean and median of reaction
times respectively. Panels C and G show fastest and slowest 10% reaction times while D and H depict reciprocals of them in respective orders. The significance
shown with dashed line indicates baseline comparisons of two cycles. The comparison with solid lines is between different time points of respective cycles. n,
number; RT, reaction time; ms, milliseconds; s−1, per second; PVT-RS, psychomotor vigilance test reaction speed; p, level of significance; p,∗ level of significance
value with less than 0.05.
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TABLE 2 | Oxygen saturation, acute mountain sickness and trail making tests during acute and acclimatization exposures.
Variables Cycle 1 Cycle 2
Baseline SL HA1 HA6 Recover SL Baseline SL HA1 HA6 Recover SL
SpO2 (%) 98.0 ± 0.9 80.2 ± 4.7∗ 83.7 ± 4.5∗† 98.0 ± 1.2 98.4 ± 1.1 82.8 ± 6.6∗ 85.0 ± 4.0∗ 97.8 ± 1.3
Lake Louise Score (LLS) 0.8 ± 1.4 5.4 ± 3.1∗ 1.9 ± 2.0† 0.5 ± 0.8 1.7 ± 1.8 4.2 ± 2.7∗ 2.0 ± 2.1† 0.9 ± 1.2
AMS, n (%) – 12 (57) 2 (10) – 1 (5) 6 (29) 2 (10) –
AMS-C (ESQ) 0.1 ± 0.2 1.0 ± 0.8∗ 0.2 ± 0.2† 0 ± 0.1 0.1 ± 0.2 0.6 ± 0.6∗ 0.2 ± 0.3† 0 ± 0
AMS, n (%) – 13 (62) 0 (0) – 1 (5) 6 (29) 2 (10) –
Trail making test (TMT)
Time (s) 49.0 ± 11.5 48.1 ± 13.3 42.4 ± 9.7∗† 41.3 ± 8.8 41.5 ± 9.4 41.3 ± 9.6 37.7 ± 8.2∗† 37.1 ± 7.9
Values are means ± SD. SL, sea level; HA1, high altitude at day 1; HA6, high altitude day 6; n, numbers; SpO2, blood oxygen saturation; LLS, Lake Louise Score;
AMS, acute mountain sickness; AMS-C, acute mountain sickness – cerebral; ESQ, Environmental Symptom Questionnaire. an = 20; ∗p < 0.05: Different from respective
baseline SL; †p < 0.05: Different from respective HA1.
(Cycle 2). The clinical outcome measures were returned to the
baseline during recovery period, i.e., after returning to sea level.
DISCUSSION
Major Findings
Several novel findings emerged from this study. First, the PVT-
RS was reduced with acute exposure to HA and normalized with
acclimatization over 6 days. Further, acclimatization effects were
retained upon re-exposure to altitude even after spending a week
at sea level. Second, there were 62% and 29% of individuals
suffering from AMS in Cycle 1 and Cycle 2, respectively,
with an immediate HA exposure. However, after 6 days of
acclimatization, the incidence of AMS was significantly reduced
to none and 10% in Cycle 1 and Cycle 2, respectively. The
incidence of AMS, during acute exposures (HA1), was decreased
by more than 50% in Cycle 2 compared to Cycle 1. Third, total
estimated sleep time were decreased during Cycle 2. Fourth,
the AMS score was associated with worsened PVT performance
(decrease in reaction speed and increase in mean reaction
time). This appears to be unrelated to estimated sleep duration
and blood oxygen saturation. The altitude-naive individuals
recovered upon descending to sea level after each cycle.
The Psychomotor Vigilance Test:
Daytime Alertness/Sustained Attention
Sleep-disordered breathing and intermittent hypoxia are
associated with excessive daytime sleepiness, loss of focus,
memory impairment, and difficulty with tasks that demand
sustained attention (Morrell and Twigg, 2006; Dempsey
et al., 2010; Beaudin et al., 2017a,b). The PVT, a validated
neurocognitive assay for sustained vigilance attention (Dorian
et al., 2005; Lim and Dinges, 2008), is impaired in patients
with sleep-disordered breathing (Sforza et al., 2004; Kim et al.,
2007), sleep-deprived individuals (Lim and Dinges, 2008; Basner
and Dinges, 2011), circadian rhythm mismatch (Van Dongen
and Dinges, 2005), and in professionals whose work demands
continuous focus in challenging operational environments
such as aviation pilots, field engineers, and military personnel
(Gander et al., 2014, 2016; Shattuck and Matsangas, 2015; Song
et al., 2017). The PVT reaction speed, lapses, mean, and median
reaction times as well as fastest and slowest 10% reaction times
are particularly sensitive in assessing alertness among sleep-
deprived individuals (Dorian et al., 2005; Basner and Dinges,
2011). The PVT has also been tested at HA among healthy
individuals, in whom no changes in PVT parameters were noted
despite a considerable number of periodic breathing episodes
and sleep disturbances (Latshang et al., 2013). Seemingly,
contrary to this finding, we report impairments in mean/median
reaction times, reaction speed, and reciprocal of slowest 10%
reaction time during acute exposure (Figure 2) while sleeping
at moderate altitude and traveling to very HA during the day.
The discrepancy in these PVT outcomes might be due to
the magnitude and duration of altitude exposure (i.e., overall
study design difference). In the previous study (Latshang et al.,
2013), the highest altitude gained was 2590 m asl whereas the
sleeping altitude in our expedition was 2900 m asl and study
participants were exposed to 5050 m asl daily for about 6–8 h
per day. The PVT-RS during acute exposure was lower at ALMA
(4.1 s−1) vs. 2590 m (5.0 s−1). The PVT changes improved
after acclimatization over 6 days – the acclimatization effect was
retained during Cycle 2 exposure after spending a week at sea
level (except for the reciprocal of slowest 10% reaction time that
followed a similar pattern as in Cycle 1) (Figure 2). The TMT
showed improvement over time at altitude, which might be due
to learning effects with acclimatization (Pagani et al., 1998; Buck
et al., 2008).
Sleep at Altitude: Sleep Indices From
Actigraphy
We assessed sleep with wrist actigraphy (Sadeh, 2005) which
has also been used at HA, having been validated against the
gold standard technique of polysomnography (Latshang et al.,
2016). The sleep indices from actigraphy in Cycle 1 (baseline
and subsequent five nights at altitude) and Cycle 2 (baseline,
seven nights at altitude, and recovery at sea level) were not
significantly different across all time points (Table 3). However,
on comparing three time points (i.e., baseline, acute, and
acclimatization exposure), the total sleep time was impaired
during the 5th night at altitude compared to the baseline and
1st night at altitude in Cycle 1. Similarly, the time in bed
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FIGURE 3 | Effect of altitude on actigraphy sleep indices during acute and acclimatization exposure. It has two panels as Cycle 1 (Left, A,B) and Cycle 2 (Right,
C,D). The Y-axis depicts sleep parameters with the mean ± standard deviation (Mean ± SD) at baseline, acute exposure (1st night altitude), and acclimatization
night (5th night at altitude). The X-axis depicts different sleep parameters as reported from actigraphy during the first expedition of Cycle 1 and Cycle 2. Black bars,
baseline sleep at Santiago, Chile (520 m asl); gray bars, acute exposure to altitude, i.e., 1st night sleep at high altitude (2900 m asl) and empty bars, sleep after
acclimatization at high altitude, i.e., 5th night sleep at high altitude in each cycle. The significance shown with dashed line indicates baseline comparisons of two
cycles. The comparison with solid lines is between different time points of respective cycles. TIB, time in bed; TST, total sleep time; SL, sleep latency; WASO, wake
after sleep onset; Awak, awakenings; SE, sleep efficiency; SD, standard deviation; min, minute; p, level of significance; n, number; %, percentage; ∗p, level of
significance value with less than 0.05.
tended to decrease on the 5th night compared to the 1st
night, and wakefulness after sleep onset tended to increase
on the 5th night compared to baseline (Figure 3). During
Cycle 2, we found both time in bed and total sleep time
were decreased on the 5th night compared to baseline and
1st night at altitude (Figure 3). It is noteworthy that in
both cycles, we observed impaired total estimated sleep time
(actigraphy), which is in agreement with previous reports of
polysomnography parameters at altitude (Latshang et al., 2016).
The sleep disturbance as reflected in TST appears to have
significantly affected from 3rd night onward. The inflexion
point of sleep disturbance may be related to the time domains
of hypoxic ventilatory acclimatization at HA (Pamenter and
Powell, 2016). Worsening sleep indices with acclimatization are
in contrast to the improvements observed in PVT performances
and blood oxygen saturation. The findings on sleep indices are
consistent with Latshang et al. (2013) who found disturbance
in nocturnal breathing and sleep during first four nights of
altitude stay although they did not find similar changes in PVT
performance. The PVT performance seems to be influenced by
improvements in AMS symptoms and blood oxygen saturation
rather than sleep disturbance. The decreased total sleep time
index might be related to HA periodic breathing, which is a
consequence of an exaggerated hypoxic ventilatory response
(Lahiri et al., 1983). Alternatively, individuals might have been
sleep deprived and exhausted in the 1st nights after the transfer
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FIGURE 4 | Inverse correlation between reaction speed vs. AMS-C score and positive association with changes in reaction time (HA1 – BL) vs. AMS-C score. It has
two panels, left panel (A) shows negative correlation between PVT-RS vs. AMS score and the right panel (B) shows positive correlation between changes in reaction
time (HA1 – BL) vs. AMS score. The Y-axis depicts reaction speed during the first exposure at altitude in A and the changes in reaction times (HA1, reaction time of
high altitude at Day 1 – BL, reaction time at baseline) in B during acute exposure at altitude during Cycle 1. In both panels, the X-axis depicts AMS-C score during
the acute exposure Cycle 1. The vertical dashed red lines in both panels separates no AMS subjects from AMS with the cut-off of a ≥ 0.7 AMS-C score. In B, the
horizontal dashed line passing through zero of Y-axis is a reference line separating negative (i.e., subjects with decreased reaction time at high altitude) and positive
(i.e., subjects with increased reaction time at high altitude) values of changes in reaction times. PVT-RS, psychomotor vigilance test reaction speed; AMS, acute
mountain sickness; AMS-C, acute mountain sickness – cerebral; BL, baseline at low altitude; HA1, acute high altitude exposure; s, seconds; ms, milliseconds; r,
Pearson’s correlation; p, level of significance.
from sea level and therefore might have required recovery sleep
time.
Acute Mountain Sickness and Blood
Oxygen Saturation
We found very high AMS incidence (62%) with acute altitude
exposure, which decreased with acclimatization (none) in Cycle
1, and the acclimatization benefit was observed in Cycle 2 as well
(29% vs. 10%). The acclimatization gained in Cycle 1 reduced
AMS incidence by > 50% during acute exposure of Cycle 2. The
findings are consistent with previous studies that acclimatization
reduces AMS incidence and severity but not entirely protective
(Beidleman et al., 2004; Jackson et al., 2010; Muza et al., 2010;
Schommer et al., 2010). We used both the LLS (Roach et al.,
1993) and the AMS-C (Sampson et al., 1983) scores for the
diagnosis of AMS (Maggiorini et al., 1998; Dellasanta et al., 2007),
and they were in agreement with each other in most instances
(Table 2). Similar to Nussbaumer-Ochsner et al. (2012), we found
improved oxygen saturation after acclimatization, but we did
not observe an improvement in sleep indices. The acute and
acclimatization exposures influenced arterial blood pressures in
both cycles compared to their respective baselines (Table 1). The
peak HG strength changed during altitude exposures returned to
closer to the baseline during acclimatization exposures (Table 1).
Higher AMS-C scores (i.e., more severe symptoms of AMS)
were negatively correlated with the PVT-RS (Figure 4A) during
acute exposure of Cycle 1. Hence, AMS seems to adversely affect
alertness and performances that require sustained attention.
Similarly, increasing reaction time (i.e., increased the change in
reaction time) was positively correlated with the AMS-C score
(Figure 4B); individuals who had higher AMS scores took longer
to react to PVT stimuli. The findings suggest that the individuals
suffering from AMS might struggle to perform delicate
work tasks such as maintenance, scientific observations, and
reporting, engineering and operation of heavy-duty equipment.
Furthermore, multiple regression analysis revealed that except
AMS-C score, the estimated sleep duration and blood oxygen
saturation are not associated with PVT-RS (Table 4). The findings
further support the previous evidence that hypoxia resulting
from HA has global cerebral effects (Kramer et al., 1993; Wilson
et al., 2009; Maa, 2010; Roach et al., 2014). The associations were
abolished after acclimatization (HA6, i.e., during HA exposure
at Day 6). Further, the acclimatization obtained in Cycle 1
was carried over during Cycle 2 even after 1 week of LA rest.
These findings support the practice followed by the Chilean HA
mining workers (Richalet et al., 2002; Farias et al., 2006). The
assessment of AMS along with the incorporation of PVT could
provide insight into the status of HA illness and its impact on
alertness/fatigue and safety margins during HA work (Vearrier
and Greenberg, 2011; Abe et al., 2014).
Strengths and Limitations
This study was designed to replicate a typical work schedule
and ascent profile of the employees at the ALMA Observatory
(Chile) with two working cycles separated by a week of rest
at LA. The 1-week break at LA is an attempt to minimize
the ill effects of long-term sustained chronic hypobaric hypoxia
(Richalet et al., 2002; Vearrier and Greenberg, 2011) and at
the same time return to work while the acclimatization effects
acquired in the previous exposure(s) are still retained (Farias
et al., 2006; Muza et al., 2010). However, the extent to which
this exposure profile is effective to optimize acclimatization
while mitigating AMS symptoms has been explored for the
first time. Hence, this study provides insight into the workers’
schedule in relation to optimum schedule to maximize their
work output while increasing work safety and reducing health
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risks. Therefore, the results from this study have implications in
reducing health hazards and improving work performance for
individuals engaging in HA activities that require high daytime
attentiveness such as astronomical observation, engineering,
computing, scientific reporting, and operation of heavy-duty
equipment.
Our study has a few limitations. First, our sample contains
a relatively small group of 21 active young individuals. Due
to logistical reasons, the expedition was designed only for two
regular work cycles. Workers at the ALMA Observatory are
older (ALMA workers’ average age is between 35 and 40 years),
and they have been working for longer durations (i.e., repeated
cycles of HA exposure throughout the year). Second, we could
only retrieve complete actigraphy data sets from 18 individuals
during Cycle 1 (and up to 5 nights) and 14 individuals during
Cycle 2 (complete cycle). Finally, we had relatively heterogeneous
population with the mixture of nationalities (Canadians and
Swiss) and their background of altitude exposure (Calgary,
1100 m asl; Zurich, 490 m asl).
CONCLUSION
The present study reports novel findings from repeated exposures
to very HA with sleep at HA interspersed with a week of break
at low attitude. With acute exposure to HA, individuals suffered
from decreased PVT performances, hypoxemia, and increased
incidence of AMS. After acclimatization, the individuals revealed
slightly less hypoxemia, a lower incidence of AMS and had
improved sustained attention functions. The acclimatization
effect acquired over a week of HA exposure was retained on a
subsequent cycle of exposure even after spending 1 week at near
sea level. The individuals with higher AMS-C scores had impaired
psychomotor reaction speeds. The sleep indices, especially total
estimated sleep time, were worsened during re-exposure, showing
no influence of acclimatization on sleep, which is similar to the
previous observations that sleep disturbances such as periodic
breathing continue to occur (Bloch et al., 2010) despite improved
clinical outcome parameters and PVT performances.
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